Future studies will be needed to determine whether CK1δ inhibition can reverse cognitive deficits in vivo and to explore whether this axis plays a broader role in other neurodegenerative or lysosomal storage disorders where SNAPIN function is compromised. The gene discussed is SNAPIN; the disease is lysosomal storage disease.